NYSE$AHR

American Healthcare REIT Inc · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Briefing

American Healthcare REIT reported Q4 2025, revenue of $450M, net income of $10.8M.

For Q4 2025, American Healthcare REIT reported revenue of $450M, net income of $10.8M. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.

  • Revenue $450M.
  • Net income $10.8M.
  • American Healthcare REIT MD&A covers liquidity, credit, and operating priorities.

Headline financials

Total Revenue

$450M

Previous: $543M-17.1%
EPS (adj)

$0.46

Previous: $0.40+15.0%
SHOP SS NOI Growth

24.6%

No prior period
Total Portfolio SS NOI Growth

11.8%

No prior period
ISHC SS NOI Growth

14.0%

No prior period
Outpatient Medical SS NOI Growth

2.2%

No prior period
Triple-Net SS NOI Growth

1.8%

No prior period
Net Debt to Annualized Adj EBITDA

3.4

No prior period
Net Income

$10.8M

Previous: -$31.8M+134.0%
Operating Income

$36.4M

Previous: $24.5M+48.6%

Revenue & EPS history

American Healthcare REIT Inc · Revenue · Quarterly

$450M

Q4 2025-17.1%vs Q4 2024
Beat estimate in 3 of 8 quarters(38%)
ActualEstimate

Revenue by segment

American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024

  • ISHC
    $423M
  • SHOP
    $73.5M
  • Outpatient Medical
    $33.3M
  • Triple-Net Leased
    $12.6M

Forward guidance

The quarterly filing discusses operating priorities, capital returns, and sector risks; numeric multi-quarter bridges vary by issuer.

Tailwinds

  • MD&A highlights liquidity, capital, and core business trends.
  • Segment or product commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure near-term margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 11 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

+1.8%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.9%

Avg return

30 days after

64%

7 / 11 earnings

Positive

+8.3%

Q1 2025

Best reaction

-2.1%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.3%+4.1%-4.2%
Q4 2025-2.1%-2.5%-11.4%
Q3 2025+3.0%-0.1%+4.6%
Q2 2025+1.3%+2.0%+7.2%
Q1 2025+8.3%+6.1%+10.2%
Q4 2024-1.3%+0.7%+0.8%
Q3 2024+1.2%+2.7%+7.1%
Q2 2024+3.3%+3.6%+35.1%
Q1 2024-0.1%+3.5%+6.2%
Q2 2023+2.8%+1.3%-6.8%
Q4 2023-0.8%+3.2%-5.9%
Q3 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022
Q4 2021
Q3 2021
Q2 2021
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q3 2018
Q2 2018
Q1 2018
Q3 2017
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro